Interleukin 2 receptor antagonists for kidney transplant recipients-Reference-Cited by-同舟云学术

Interleukin 2 receptor antagonists for kidney transplant recipients

Published:2010-01-20 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Webster Angela C¹,Ruster Lorenn P²,McGee Richard G³,Matheson Sandra L²,Higgins Gail Y⁴,Willis Narelle S⁴,Chapman Jeremy R⁵,Craig Jonathan C³

Affiliation:

1. The University of Sydney at Westmead; Centre for Transplant and Renal Research, Westmead Millennium Institute; Westmead NSW Australia 2145

2. The Children's Hospital at Westmead; Centre for Kidney Research; Locked Bag 4001 Westmead NSW Australia 2145

3. The University of Sydney; Sydney School of Public Health; Sydney NSW Australia 2006

4. The Children's Hospital at Westmead; Cochrane Renal Group, Centre for Kidney Research; Locked Bag 4001 Westmead NSW Australia 2045

5. Westmead Millennium Institute, The University of Sydney at Westmead; Centre for Transplant and Renal Research; Darcy Rd Westmead NSW Australia 2145

Publisher

Wiley

Subject

Pharmacology (medical)

Reference409 articles.

1. CMV infections after two doses of daclizumab versus thymoglobulin in renal transplant patients receiving mycophenolate mofetil, steroids and delayed cyclosporine A;Abou-Ayache;Nephrology Dialysis Transplantation,2008

2. Two-dose daclizumab induction treatment versus thymoglobuline in renal transplant patients receiving a mycophenolate mofetil based immunosuppression [abstract no: 121];Abou-Ayache;American Journal of Transplantation,2005

3. Limited dose monoclonal IL-2R antibody induction protocol after primary kidney transplantation;Ahsan;American Journal of Transplantation,2002

4. Limited dose monoclonal IL-2R antibody induction in kidney transplantation - a prospective, randomized, controlled clinical trial [abstract];Ahsan;American Journal of Transplantation,2002

5. Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipients;Asberg;Transplantation,2006

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of single‐dose anti‐thymocyte globulin versus basiliximab induction therapy in pediatric kidney transplant recipients: A retrospective comparative cohort study;Pediatric Transplantation;2024-03-29

2. The use of lymphocyte-depleting antibodies in specific populations of kidney transplant recipients: A systematic review and meta-analysis;Transplantation Reviews;2023-12

3. Outcomes of thymoglobulin versus basiliximab induction therapies in living donor kidney transplant recipients with mild to moderate immunological risk – a retrospective analysis of UNOS database;Annals of Medicine;2023-05-26

4. Basiliximab induction versus no induction in adult heart transplantation;Clinical Transplantation;2023-02-26

5. Very Low Dose Anti-Thymocyte Globulins Versus Basiliximab in Non-Immunized Kidney Transplant Recipients;Transplant International;2023-02-03